With ongoing research and development, these pumps are likely to become increasingly sophisticated, addressing not only the physiological aspects of insulin delivery, but also the practical concerns of patients, ultimately improving diabetes management and quality of life. This evidence concerns the gene INS and diabetes mellitus.